Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Immuneering Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 34 | +3 |
| Shares | 12.1M | 58.6K | 11.7M | −282.1K (−2.3%) |
| Value | $172.5M | $840.0K | $56.9M | −$114.8M (−66.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Immuneering Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CI Private Wealth, LLC | 47,419 | $230.0K | 0.00% |
| Susquehanna International Group, LLP | 45,000 | $218.3K | 0.00% |
| Anson Funds Management LP | 32,603 | $158.1K | 0.05% |
| Man Group plc | 18,368 | $89.1K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,148 | $20.1K | 0.00% |
| Credit Suisse AG | 58 | $281 | 0.00% |
| Royal Bank of Canada | 81 | $0 | 0.00% |
Sold out (4)
Institutions that held Immuneering Corp at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Buckingham Strategic Wealth, LLC | 200,200 | $2.87M |
| Marshall Wace, LLP | 67,160 | $962.0K |
| Balyasny Asset Management LLC | 11,366 | $163.0K |
| UBS Group AG | 105 | $2.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Immuneering Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Kore Private Wealth LLC | 58,649 | $840.0K |